Although little has been studied about its role in breast cancer (112), S100A13 is known to regulate fibroblast growth factor (FGF1) and IL1α, which can affect the angiogenic and mitogenic properties of the tumor microenvironment (113–115). The gene discussed is S100A13; the disease is neoplasm.